Proposed Norton drug plant signals more pharmaceutical manufacturing in Massachusetts

SourceSun Chronicle
Date Published02/15/2016
Author NameJim Hand
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Parent companyAlnylam Pharmaceuticals
Reshoring category:Kept from Offshoring
Total number of jobs (added or to be added):370
Year reshoring announced:2016
Domestically, the work will be done:In-house
Capital investment ($):$200
City reshored to:Norton
State(s) reshored to:MA
If relevant, work nearshored to:-
What domestic positive factors made reshoring more attractive?Government Incentives, Skilled workforce availability/training
Government Incentive dollar amount:$7 million
Find Reshoring Articles